Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Memory Lift Safeness Issues Arise: Do NOT Buy from Third-Party Retail Websites to Avoid Side Effects Risk

March 20, 2026

CityPlace Welcomes Moxies as New Social Dining Destination

March 20, 2026

Yanik Guillemette Warns of “Innovation Crisis” as Bill C-22 Threatens Canada’s Digital Economy and Global Competitiveness

March 20, 2026

Jelly Lean (URGENT REPORT 2026) Is It Legit? Benefits, Ingredients, Official Website, Complaints, and Customer Feedback

March 20, 2026

Ottawa stands by ‘Havana syndrome’ report as U.S. reconsiders foreign role

March 20, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Global G-Protein Coupled Receptors Market To Reach $5.23 Billion By 2030 With High-Throughput Screening Boosting Growth
Press Release

Global G-Protein Coupled Receptors Market To Reach $5.23 Billion By 2030 With High-Throughput Screening Boosting Growth

By News RoomDecember 8, 20233 Mins Read
Global G-Protein Coupled Receptors Market To Reach .23 Billion By 2030 With High-Throughput Screening Boosting Growth
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Dec. 08, 2023 (GLOBE NEWSWIRE) — The “G-Protein Coupled Receptors Market Size, Share & Trends Analysis Report By Product (Cell Lines, Detection Kits, Cell Culture Reagents, Ligands), By Assay Type, By Application, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.

The global G-protein coupled receptors market size is expected to reach USD 5.23 billion by 2030 registering a CAGR of 5.1%. Rising adoption of faster and accurate High-Throughput Screening (HTS) technology by pharmaceutical firms to develop potential G-protein coupled receptor(GPCR)-targeted therapeutics is expected to augment the market growth. HTS is used on the G-protein coupled receptor cell-based assays to assist several drug development programs.

Structural and functional features of G-protein coupled receptors (GPCRs) allow it to mediate physiological responses to hormones, stimulants, and neurotransmitters, thus making them as potential therapeutic targets for various diseases. Recent advancements in the structural biology of GPCRs have provided insights into the molecular mechanisms of these receptors’ activation and activity. Several pharmaceutical companies are undertaking efforts to develop G-protein coupled receptors-targeted therapeutics for several disorders.

In December 2018, Boehringer Ingelheim collaborated with Domain Therapeutics to discover GPCR targets for the treatment of cancer, Central Nervous System (CNS), and immunological disorders. Moreover, in May 2019, Evotec OAI AG partnered with Euroscreen S.A. to improve its capabilities for GPCR targeting. Evotec OAI will access GPCR reagents and AequoScreenTM technology of Euroscreen for its drug discovery procedures. Such initiatives enhance the product adoption as well as drug screening expertise in the pharmaceutical industry.

North America is likely to be at the forefront of the market throughout the forecast period due to heavy investments in cancer research to address the rising demand for drug discovery and development procedures in U.S. Whereas, Asia Pacific is expected to register the fastest CAGR over the forecast years. The region witnesses a rising number of therapeutics development and contract research, thus boosting G-protein coupled receptors market growth.

G-Protein Coupled Receptors Market Report Highlights

  • Easy availability of cell lines products and a large number of companies offering a variety of cell lines resulted in the largest revenue share of cell lines in 2022
  • Increasing usage of fully equipped detection kits instead of cell lines, reagents, and ligands separately, marks the potential growth of detection kits in the near future
  • cAMP assays serve as a versatile platform in HTS for explaining the GPCR functions, which results in maximum revenue generation from these type of assays
  • Cancer research application accounted for the largest revenue share in 2022 owing to increased number of cancer cases and investments in oncology R&D
  • Ongoing research studies to evaluate the pharmacology of GPCRs in chronic inflammatory disorders reveals immense opportunities for research in inflammatory applications
  • Acquisition, partnerships, and collaborations are the major strategies adopted by these companies to offer new GPCR-targeted medicines, thereby strengthening their presence in the global GPCRs market

Key Attributes:

Report Attribute Details
No. of Pages 135
Forecast Period 2022 – 2030
Estimated Market Value (USD) in 2022 $3.46 Billion
Forecasted Market Value (USD) by 2030 $5.23 Billion
Compound Annual Growth Rate 5.1%
Regions Covered Global

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • QIAGEN
  • WuXi AppTec
  • Promega Corporation
  • Abcam plc
  • Merck KGaA
  • PerkinElmer Inc.
  • Enzo Biochem Inc.
  • BD

For more information about this report visit https://www.researchandmarkets.com/r/4fvwsk

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global G-Protein Coupled Receptors Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Memory Lift Safeness Issues Arise: Do NOT Buy from Third-Party Retail Websites to Avoid Side Effects Risk

CityPlace Welcomes Moxies as New Social Dining Destination

Yanik Guillemette Warns of “Innovation Crisis” as Bill C-22 Threatens Canada’s Digital Economy and Global Competitiveness

Jelly Lean (URGENT REPORT 2026) Is It Legit? Benefits, Ingredients, Official Website, Complaints, and Customer Feedback

TRACE ASI Launches Advanced Market Analysis Platform Powered by Artificial Intelligence

Sugar Harmony: The TRUTH Behind the “5-Drop Morning Hack” and Hidden Ingredient Dangers

All California University of Science and Medicine MD Graduates Receive Residency Placements during Match Day 2026

Accolad: The Employee Recognition Platform Revolutionizing HR Programs in Canada

OFC 2026 Delivers a High-Impact Week Marked by Breakthrough Announcements, Strong Attendance and Global Momentum in AI Infrastructure and Optical Networking

Editors Picks

CityPlace Welcomes Moxies as New Social Dining Destination

March 20, 2026

Yanik Guillemette Warns of “Innovation Crisis” as Bill C-22 Threatens Canada’s Digital Economy and Global Competitiveness

March 20, 2026

Jelly Lean (URGENT REPORT 2026) Is It Legit? Benefits, Ingredients, Official Website, Complaints, and Customer Feedback

March 20, 2026

Ottawa stands by ‘Havana syndrome’ report as U.S. reconsiders foreign role

March 20, 2026

Latest News

TRACE ASI Launches Advanced Market Analysis Platform Powered by Artificial Intelligence

March 20, 2026

Sugar Harmony: The TRUTH Behind the “5-Drop Morning Hack” and Hidden Ingredient Dangers

March 20, 2026

Josh Duggar reacts to brother Joseph’s arrest for child molestation

March 20, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version